NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-001-2017-0-US-01 Antibodies and Methods for the Diagnosis and Treatment of Epstein Barr Virus Infection US 62/490,023 Abandoned
NHLBI E-124-2014-3-EP-06 Device For Closure Of Transvascular Or Transcameral Access Ports EP National Stage 17786794.2 Issued
NHLBI E-124-2014-3-JP-05 Device For Closure Of Transvascular Or Transcameral Access Ports JP National Stage 2019-507068 Issued
NIAID E-124-2016-0-PCT-02 BIVALENT IMMUNOGENIC CONJUGATE FOR MALARIA AND TYPHOID PCT PCT PCT/US2017/029182 Expired
NHLBI E-124-2014-3-PCT-02 Device For Closure Of Transvascular Or Transcameral Access Ports PCT PCT PCT/US2017/029094 Expired
NHLBI E-152-2018-0-US-01 Fluorogen-binding RNA Aptamers US 62/489,346 Abandoned
NIDDK E-138-2017-0-BR-01 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS BR DIV BR122024020857-1 Issued
NIDDK E-138-2017-0-HK-17 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS HK EP 19127110.5 Issued
NIDDK E-138-2017-0-BR-07 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS BR National Stage BR112018071560-3 Issued
NIDDK E-138-2017-0-EA-04 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS EA National Stage 201892008 Issued
NIDDK E-138-2017-0-AU-03 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS AU National Stage 2017254720 Issued
NIDDK E-138-2017-0-JP-09 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS JP National Stage 2018-555672 Issued
NIDDK E-138-2017-0-MX-10 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS MX National Stage MX/a/2018/012655 Issued
NIDDK E-138-2017-0-CN-14 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS CN National Stage 201780024816.X Issued
NICHD E-552-2013-0-US-13 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE US CON 15/493,622 10113183 Issued PDF
NIDDK E-138-2017-0-PCT-02 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS PCT PCT PCT/US2017/028996 Expired
NIDDK E-138-2017-0-IN-15 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS IN National Stage 201817040537 Abandoned
NIDDK E-138-2017-0-ZA-12 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS ZA National Stage 2018/06713 Pending
NIDDK E-138-2017-0-KR-01 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS KR DIV 10-2022-7032219 Pending
NIDDK E-138-2017-0-CA-13 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS CA National Stage 3020490 Pending
NICHD E-211-2021-0-US-01 Systems And Methods To Predict Risk For Preterm Labor And/or Preterm Birth US 62/488,653 Abandoned
NCI E-131-2016-0-JP-06 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO JP National Stage 2018-555639 Issued
NCI E-131-2016-0-PCT-02 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO PCT PCT PCT/US2017/028628 Expired
NCI E-131-2016-0-CA-04 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO CA National Stage 3021569 Pending
NCI E-269-2010-0-JP-11 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE JP DIV 2017-082965 Abandoned
NEI E-119-2017-0-US-01 IL-24 TO TREAT INFLAMMATORY DISEASES US 62/487,223 Abandoned
NIAID E-099-2016-0-EP-08 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS EP National Stage 17723547.0 Issued
NIAID E-099-2016-0-KR-11 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS KR National Stage 10-2018-7033500 Issued
NIAID E-099-2016-0-AU-05 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS AU National Stage 2017253935 Abandoned
NIAID E-145-2015-3-NL-13 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV NL EP 15841780.8 Issued
NIAID E-145-2015-3-FR-09 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV FR EP 15841780.8 Issued
NIAID E-145-2015-3-DE-07 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV DE EP 15841780.8 Issued
NIAID E-145-2015-3-IE-11 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV IE EP 15841780.8 Issued
NIAID E-145-2015-3-IT-12 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV IT EP 15841780.8 Issued
NIAID E-145-2015-3-ES-08 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV ES EP 15841780.8 Issued
NIAID E-145-2015-3-CH-06 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV CH EP 15841780.8 Issued
NIAID E-145-2015-3-EP-03 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV EP National Stage 15841780.8 Issued
NIAID E-145-2015-3-GB-10 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV GB EP 15841780.8 Issued
NIAID E-099-2016-0-PCT-02 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS PCT PCT PCT/US2017/028133 Expired
NIAID E-099-2016-0-CN-07 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS CN National Stage 201780038148.6 Abandoned
NIAID E-099-2016-0-HK-20 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS HK EP 19127785.4 Pending
NIAID E-099-2016-0-JP-10 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS JP National Stage 2018-553392 Abandoned
NIAID E-099-2016-0-MX-12 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS MX National Stage MX/a/2018/012719 Abandoned
NIAID E-099-2016-0-SG-13 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS SG National Stage 11201809100Q Abandoned
NIAID E-099-2016-0-IL-09 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS IL National Stage 262455 Abandoned
NIAID E-099-2016-0-CA-06 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS CA National Stage 3020863 Abandoned
NCI E-263-2011-0-US-09 PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC B CELL EPITOPES US DIV 15/488,898 10111927 Issued PDF
NCI E-153-2016-0-PCT-02 ANTI-KK-LC-1 T CELL RECEPTORS PCT PCT PCT/US2017/027865 Expired
NCI E-308-2000-0-US-16 Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same US CON 15/489,130 Abandoned
NCI E-153-2016-0-CA-04 ANTI-KK-LC-1 T CELL RECEPTORS CA National Stage 3021898 Pending